RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/38980635/ below:

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Guideline

. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024 Lidwine B Mokkink², Caroline B Terwee², Dorcas Beaton³, Joel J Gagnier⁴, Andrea C Tricco^{5 6 7}, Ami Baba¹, Nancy J Butcher^{1 8}, Maureen Smith⁹, Catherine Hofstetter¹⁰, Olalekan Lee Aiyegbusi¹¹, Anna Berardi^{12 13}, Julie Farmer¹⁴, Kirstie L Haywood¹⁵, Karolin R Krause¹⁶, Sarah Markham¹⁷, Evan Mayo-Wilson¹⁸, Ava Mehdipour¹⁹, Juanna Ricketts^#²⁰, Peter Szatmari¹⁶, Zahi Touma²¹, David Moher²², Martin Offringa^{23 24}

Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, ON, Canada.
⁴ Department of Epidemiology & Biostatistics and Department of Surgery, Western University, London, ON, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
⁶ Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁷ Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁸ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁹ Cochrane Consumer Network, London, UK.
¹⁰ OMERACT Patient Research Partner, Toronto, ON, Canada.
¹¹ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹² Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
¹³ IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹⁴ Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
¹⁵ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁶ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁸ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC, 27599, USA.
¹⁹ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
²⁰ Patient Partner, Halifax, NS, Canada.
²¹ Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
²² Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²³ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. martin.offringa@sickkids.ca.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. martin.offringa@sickkids.ca.

PMID: 38980635
PMCID: PMC11286641
DOI: 10.1007/s11136-024-03634-y

Item in Clipboard

Guideline

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Ellen B M Elsman et al. Qual Life Res. 2024 Aug.

. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9. Authors Ellen B M Elsman^{1 2}, Lidwine B Mokkink², Caroline B Terwee², Dorcas Beaton³, Joel J Gagnier⁴, Andrea C Tricco^{5 6 7}, Ami Baba¹, Nancy J Butcher^{1 8}, Maureen Smith⁹, Catherine Hofstetter¹⁰, Olalekan Lee Aiyegbusi¹¹, Anna Berardi^{12 13}, Julie Farmer¹⁴, Kirstie L Haywood¹⁵, Karolin R Krause¹⁶, Sarah Markham¹⁷, Evan Mayo-Wilson¹⁸, Ava Mehdipour¹⁹, Juanna Ricketts^#²⁰, Peter Szatmari¹⁶, Zahi Touma²¹, David Moher²², Martin Offringa^{23 24} Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, ON, Canada.
⁴ Department of Epidemiology & Biostatistics and Department of Surgery, Western University, London, ON, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
⁶ Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁷ Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁸ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁹ Cochrane Consumer Network, London, UK.
¹⁰ OMERACT Patient Research Partner, Toronto, ON, Canada.
¹¹ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹² Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
¹³ IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹⁴ Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
¹⁵ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁶ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁸ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC, 27599, USA.
¹⁹ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
²⁰ Patient Partner, Halifax, NS, Canada.
²¹ Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
²² Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²³ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. martin.offringa@sickkids.ca.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. martin.offringa@sickkids.ca.

PMID: 38980635
PMCID: PMC11286641
DOI: 10.1007/s11136-024-03634-y

Item in Clipboard

Abstract

Purpose: Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.

Methods: The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.

Results: From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review's title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.

Conclusion: PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

Keywords: COSMIN; Measurement properties; Outcome measurement instrument; PRISMA; Reporting guideline; Systematic reviews.

PubMed Disclaimer

Conflict of interest statement

Drs. Terwee and Mokkink are the founders of COSMIN; Dr. Moher is a member of the PRISMA executive; Dr. Tricco is the co-editor in chief of the Journal of Clinical Epidemiology. The other authors have no conflicts of interest.

Figures
Fig. 1

Development process of PRISMA-COSMIN for…

Fig. 1

Development process of PRISMA-COSMIN for OMIs 2024. E&E explanation and elaboration; EQUATOR Enhancing…

Fig. 1

Development process of PRISMA-COSMIN for OMIs 2024. E&E explanation and elaboration; EQUATOR Enhancing the QUAlity and Transparency Of health Research; OMI outcome measurement instrument

Fig. 2

Proposals and consensus for items…

Fig. 2

Proposals and consensus for items in each Delphi round and the workgroup meeting.…

Fig. 2

Proposals and consensus for items in each Delphi round and the workgroup meeting. COSMIN COnsensus-based Standards for the selection of health Measurement Instruments; OMI outcome measurement instrument; PRISMA Preferred Reporting Items for Systematic reviews and Meta-Analyses

Fig. 3

PRISMA-COSMIN for OMIs 2024 flow…

Fig. 3

PRISMA-COSMIN for OMIs 2024 flow diagram

Fig. 3

PRISMA-COSMIN for OMIs 2024 flow diagram